Ready to invest in
Roundup® Cases?
Whitehardt is here to be your dedicated partner in securing valuable leads and cases for the highest possible return on your investment.
Request A Custom QuoteHow It Works: A Proven Path to Profit
Pick the brand you want to advertise with (or advertise with your own brand!) and decide how much you want to invest into Roundup® cases.
We make the ad at no cost to you and develop a custom media strategy designed to generate the most cases for the least amount of money.
We pass qualified leads off to your team or utilize our in-house contract services team to turn those leads into signed cases.
We deliver those lucrative Roundup® cases directly to you.
Invest in Roundup® Cases
CPL
$1,100
Current CPA
$3,000
Criteria
Diagnosed with Non-Hodgkin’s Lymphoma after using the weedkiller Roundup®
Ready to Get More Roundup® Cases?
We have 20 years of experience getting our clients high-quality leads in the most lucrative mass torts. Invest in Roundup® and let us put that experience to work for you!
Roundup® Timeline
2021
-
August
An appeal filed by Monsanto is denied by the California state appeals court. The company still owes an $86 million award to a couple who regularly use their products for over 30 years.
-
July
Bayer announces a five-point plan in response to Round-Up litigations. This plan includes replacing glyphosate in the herbicide formula by January of 2023.
-
May
On May 26th, the February motion 1 in which Bayer proposed a $2 billion settlement for future Roundup® claims was denied, signaling another promising victory for Roundup® victims and the future of Roundup® claims.
Bayer laid out several possible responses to this ruling, from pulling Roundup® off of shelves to rewriting product labels. Bayer even suggested removing glyphosate, the harmful chemical found in the product, from the Roundup® formula.
-
March
It was reported that Bayer chose not to ask the U.S. Supreme Court to hear an appeal of the first jury verdict over the safety of Roundup®, Johnson v. Monsanto. This case concluded with a $289 million settlement awarded to the plaintiff. Although that settlement was later reduced to $78 million, Bayer’s liability was upheld.
-
February
Bayer proposed a $2 billion settlement for future Roundup® claims. This proposal was later rejected in May 2021.
2020
-
September
Bayer and a number of plaintiffs’ attorneys agreed to settle 15,000 Roundup® lawsuits. The terms of the settlements were not announced.
-
August
A $10.9 billion settlement agreement meant to resolve most existing and future lawsuits over Roundup®-related illnesses encountered roadblocks. The plaintiffs’ lawyers accused Bayer of reneging on the deal, and the judge expressed concerns that Bayer was manipulating the settlement process.
-
July
Though denying Bayer’s request to overturn the verdict of the very first Roundup® lawsuit, Johnson v. Monsanto, the California appellate court further reduced the $78.5 million (originally set at $289 million) to $20.5 million.
-
June
Judge Chhabria prevented California officials from requiring that the popular weed-killing product contain a prominent safety warning on store shelves in the state.
2019
-
May
A California jury in the trial of Pilliod et al. v. Monsanto ordered Bayer to pay $2 billion in punitive damages in a lawsuit filed by a couple who both developed cancer after using Roundup® for over 30 years. The couple was also awarded another $55 million as compensation for their medical bills, pain and suffering, and other damages. A few months later, this award was reduced to $86.7 million after the judge concluded that the original settlement amount was significantly out of step with legal precedent.
-
February-March
Hardeman v. Monsanto began on February 25th and ended on March 27th with an $80M verdict, later reduced to $25.2 million.
2018
-
June-August
Johnson v. Monsanto began on June 18th and ended on August 10th. The jury ordered Bayer/Monsanto to pay $289 million to Dewayne Johnson for his non-Hodgkin’s lymphoma that he developed after using Roundup®. This amount was later reduced.
Bayer purchased glyphosate manufacturer Monsanto and its Roundup® lawsuits for $63 billion.
2015
- The World Health Organization’s cancer research sector determined Roundup® to be a “probable carcinogen.”
Roundup® MDL
Over 100,000 legal complaints have been filed against Monsanto (now owned by Bayer) from Roundup® users diagnosed with non-Hodgkin’s lymphoma. When Bayer purchased Monsanto in 2018, they also assumed ownership of all pending and future complaints. Many of these complaints were regrouped in a multidistrict litigation (MDL) assigned to the Northern District of California District Court. In July 2018, Judge Vince Chhabria concluded a reasonable jury could find that glyphosate, the active chemical in Roundup®, can cause non-Hodgkin’s lymphoma at exposure levels that users have realistically experienced.
The Magic Balance We’ve Perfected Over 20 Years
We’ve helped some of the biggest names in the business get to where they are today through our tried and tested MDL marketing strategies. With 20 years of experience and an unmatched dedication to your results, we’re here to utilize our proven formulas to bring you the highest return on your investment possible. If you’re ready to invest in a campaign that will make the phone ring while you focus on settling cases, we’re ready to make it happen in a way that is most cost-effective for you and your business.
Get More Roundup® Cases Without Lifting a Finger
We’re ready to get started. Put the industry’s leading marketing experts behind your campaign today when you request a custom quote.
Request a Custom Quote
Put our proven, results-driven team behind your quest for success.